CEM-102

· Arrevus Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CEM-102, covering 2019-04-19 to 2019-04-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections [Phase 2]